Key Takeaways
- • Manchester Fertility Services, including its Semovo brand, has been sold to TFP Fertility Group for an undisclosed sum.
- • TFP Fertility Group is backed by US private equity firm Amulet Capital Partners, which operates a growing network of clinics across the UK and Poland.
- • Manchester Fertility, founded in 1986, is one of the UK's longest established fertility providers and operates from a purpose-built clinic and laboratory in Cheadle, Greater Manchester.
- • The deal further strengthens TFP's presence in the North West of England.
Summary
Manchester Fertility Services, including the Semovo brand, has been sold to TFP Fertility Group, according to TheBusinessDesk.com. The financial terms of the transaction were not disclosed.
Manchester Fertility is one of the UK's longest established fertility providers, founded in 1986. It operates from a purpose-built clinic and laboratory in Cheadle, Greater Manchester. With the acquisition, the business joins TFP Fertility Group, which is backed by US private equity firm Amulet Capital Partners.
Amulet-backed TFP has built a growing network of fertility clinics across the UK and Poland. The transaction adds to the group's footprint in the North West, according to the report.
The source article is partially paywalled, so further details on management arrangements, clinical leadership and post-deal integration plans are not available from the available text.
Manchester Fertility is one of the UK's longest established fertility providers, founded in 1986. It operates from a purpose-built clinic and laboratory in Cheadle, Greater Manchester. With the acquisition, the business joins TFP Fertility Group, which is backed by US private equity firm Amulet Capital Partners.
Amulet-backed TFP has built a growing network of fertility clinics across the UK and Poland. The transaction adds to the group's footprint in the North West, according to the report.
The source article is partially paywalled, so further details on management arrangements, clinical leadership and post-deal integration plans are not available from the available text.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.